(19)
(11) EP 4 125 947 A1

(12)

(43) Date of publication:
08.02.2023 Bulletin 2023/06

(21) Application number: 21776517.1

(22) Date of filing: 26.03.2021
(51) International Patent Classification (IPC): 
A61K 35/12(1974.07)
A61K 35/19(2015.01)
C12M 1/26(1980.01)
C12M 3/06(1990.01)
A61K 35/14(1974.07)
C12M 1/00(1980.01)
C12M 1/34(1980.01)
(52) Cooperative Patent Classification (CPC):
A61P 37/06; C12N 5/0644; A61K 35/19; Y02A 50/30
(86) International application number:
PCT/US2021/024442
(87) International publication number:
WO 2021/195544 (30.09.2021 Gazette 2021/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.03.2020 US 202063000866 P
14.05.2020 US 202063024649 P
23.10.2020 US 202063104871 P
15.12.2020 US 202063125490 P
28.01.2021 US 202163142586 P

(71) Applicant: Platelet Biogenesis, Inc.
Watertown, Massachusetts 02472 (US)

(72) Inventors:
  • HETT, Sunita R.
    Watertown, Massachusetts 02472 (US)
  • WEISINGER, Karen
    Watertown, Massachusetts 02472 (US)
  • PENG, Yang
    Watertown, Massachusetts 02472 (US)
  • MCLAUGHLIN, Kyle P.
    Watertown, Massachusetts 02472 (US)
  • PETERS, Christian G.
    Watertown, Massachusetts 02472 (US)
  • ZUKAUSKAS, Andrew R.
    Watertown, Massachusetts 02472 (US)
  • SMITH, Brenden W.
    Watertown, Massachusetts 02472 (US)
  • GIANNINI, Silvia
    Watertown, Massachusetts 02472 (US)
  • LEE, Po-Shun
    Watertown, Massachusetts 02472 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) NOVEL ANUCLEATED CELLS FOR THE TREATMENT OF DISEASES